Occurrence of invasive SCC of the vulva and development of multiple premalignant colonic and gastric adenomas have also been described in patients with BRAF-mutant melanoma treated with vemurafenib (Boussemart et al., 2013; Gibney et al., 2013). This evidence concerns the gene BRAF and melanoma.